Camber Pharmaceuticals is voluntarily recalling 87 lots of the blood pressure drug Losartan due to traces of a potential carcinogen. The affected products come in 25, 50 and 100 milligram doses. The company urges consumers to consult their doctor before stopping treatment. Since 2018, there have been at least 19 recalls of versions of the drug over cancer fears.
